Science

Raymond Chan: Neuroactive ligand-receptor and RAS pathway disruptions linked to cancer-related cognitive impairment

Raymond Chan/LinkedIn

Mar 12, 2025, 16:34

Raymond Chan: Neuroactive ligand-receptor and RAS pathway disruptions linked to cancer-related cognitive impairment

Raymond Chan, Deputy Vice-Chancellor for Research at Flinders University, shared a post on X about a paper he co-authored with colleagues published in Supportive Care in Cancer:

“In our recent gene expression study, Neuroactive ligand-receptor interaction and RAS pathways were significantly perturbed btn cancer survivors with and without cancer-related cognitive impairment directions re potential therapeutics.”

“Perturbations in the neuroactive ligand-receptor interaction and renin angiotensin system pathways are associated with cancer-related cognitive impairment”

Authors: Raymond Chan, Adam Walker, Janette Vardy, Alexandre Chan, Kate Oppegaard, Adam Olshen, Marilyn Hammer, Jon Levine, Christine Miaskowski et al.

More posts featuring Raymond Chan.

Adam Olshen Adam Walker Alexandre Chan cancer cancer related cognitive impairment Christine Miaskowski Janette Vardy Jon Levine Kate Oppegaard Marilyn Hammer neuroactive ligand-receptor interaction OncoDaily Oncology Raymond Chan renin angiotensin system

VERITAC-2 Trial Update: Vepdegestrant Meets Primary Endpoint in ESR1-Mutant Breast Cancer

New Paper Alert: HARMONi-2 study of Ivonescimab vs pembrolizumab for PD-L1-positive non-small cell lung cancer

We are thrilled to welcome Dr. Jasmine Kamboj to the OncoDaily Editorial Board!

Oncologist Near Me – Fedro Alessandro Peccatori: Leading Expert in Gynecological Oncology

MATTERHORN trial - FLOT plus durvalumab will become the new standard of care in the preoperative setting for gastroesophageal cancer

Special Coverage